|

STC-15 monotherapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • STORM Therapeutics LTD1

Indications

  • Dedifferentiated Liposarcoma1
  • Metastatic Head and Neck Squamous Cell Carcinoma1
  • Metastatic Endometrial Cancer1
  • Leiomyosarcoma1
  • Metastatic Non-Small Cell Lung Cancer1

Lake Success, New York1 trial

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

Northwell Health Cancer Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.